Acción ASIA ASIA GREEN BIOTECHNOLOGY CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Asia Green Biotechnology Corp.

Acciones

ASIA

CA04522C1041

Mercado cerrado - Canadian Securities Exchange
Otros sitios de cotización
 19:34:38 06/02/2024 		Varia. Cinco días. Varia. 1 de enero.
0,015 CAD +50,00 % Gráfico intradía de Asia Green Biotechnology Corp. -.--% +50,00 %
24/05 Asia Green Biotechnology Corp. anuncia que Vincent Ghazar dimite como Director CI
24/05 Asia Green Biotechnology Corp. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Asia Green Biotechnology Corp. Announces Vincent Ghazar Resigns as Director
Asia Green Biotechnology Corp. Announces Resignation of Vincent Ghazar as Chief Financial Officer
Asia Green Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Asia Green Biotechnology Corp. Announces Discontinuation of Any Further Activities in Asia, in Particular, in Cambodia and Thailand
CSE Bulletin: Halted for Fundamental Change - Asia Green Biotechnology Corp. (ASIA)
Burton Growers Ltd. & Green Sight Agri-Holdings Inc. entered into a non-binding letter of intent to acquire Asia Green Biotechnology Corp. for CAD 4 million in a reverse merger transaction.
Canadian Investment Regulatory Organization Trading Halt - ASIA
Asia Green Biotechnology Corp. announced that it expects to receive CAD 1.5 million in funding
Asia Green Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Asia Green Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Asia Green Biotechnology Corp. Announces Passing of Johannes Kingma, Director
Asia Green Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Asia Green Biotechnology Corp. Partners with Pathway Rx Inc. to Pursue Clinical Trials Activities in the Development of A Migraine Treatment Utilizing Cannabis and Hemp Extracts Controlled by Pathway Inc
Asia Green Biotechnology Corp. Announces Resignation of Daryl Hudson as Director
Asia Green Biotechnology Corp. Auditor Raises 'Going Concern' Doubt
Asia Green Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Asia Green Biotechnology Corp. Proceeds to Next Phase of Migraine Clinical Study
Asia Green Biotechnology Corp. Proceeding to Next Phase of Migraine Clinical Study; Extending Financing Arrangement
Asia Green Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Asia Green Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ASIA
  4. Noticias Asia Green Biotechnology Corp.
  5. Otros idiomas
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA